Loomis, Sayles & Company’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-146,783
| Closed | -$22.9M | – | 741 |
|
|
2020
Q2 | $22.9M | Buy |
146,783
+12,894
| +10% | +$2.01M | 0.04% | 198 |
|
|
2020
Q1 | $19.3M | Buy |
133,889
+17,909
| +15% | +$2.59M | 0.04% | 170 |
|
|
2019
Q4 | $23.7M | Sell |
115,980
-105,803
| -48% | -$21.6M | 0.04% | 189 |
|
|
2019
Q3 | $17.8M | Buy |
221,783
+25,194
| +13% | +$2.02M | 0.03% | 228 |
|
|
2019
Q2 | $18.5M | Buy |
+196,589
| New | +$18.5M | 0.03% | 218 |
|